These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8275619)

  • 21. Comparison of diazepam and oxazepam: preference, liking and extent of abuse.
    Griffiths RR; McLeod DR; Bigelow GE; Liebson IA; Roache JD; Nowowieski P
    J Pharmacol Exp Ther; 1984 May; 229(2):501-8. PubMed ID: 6716272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human progressive-ratio performance: maintenance by pentobarbital.
    McLeod DR; Griffiths RR
    Psychopharmacology (Berl); 1983; 79(1):4-9. PubMed ID: 6403962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human abuse potential of brivaracetam in healthy recreational central nervous system depressant users.
    Schoedel KA; Stockis A; Sellers EM
    Epilepsy Behav; 2018 Jan; 78():194-201. PubMed ID: 29153631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of response requirement upon human sedative self-administration and drug-seeking behavior.
    Bigelow GE; Griffiths RR; Liebson IA
    Pharmacol Biochem Behav; 1976 Dec; 5(6):681-5. PubMed ID: 1023234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental human drug self-administration: methodology and application to the study of sedative abuse.
    Bigelow G; Griffiths R; Liebson I
    Pharmacol Rev; 1975 Dec; 27(4):523-31. PubMed ID: 1223915
    [No Abstract]   [Full Text] [Related]  

  • 27. Relative abuse liability of lorazepam and diazepam: an evaluation in 'recreational' drug users.
    Funderburk FR; Griffiths RR; McLeod DR; Bigelow GE; Mackenzie A; Liebson IA; Nemeth-Coslett R
    Drug Alcohol Depend; 1988 Dec; 22(3):215-22. PubMed ID: 3234245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug preference and mood in humans: diazepam.
    Johanson CE; Uhlenhuth EH
    Psychopharmacology (Berl); 1980; 71(3):269-73. PubMed ID: 6779334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-response evaluation of the amnestic effects of triazolam and pentobarbital in normal subjects.
    Kirk T; Roache JD; Griffiths RR
    J Clin Psychopharmacol; 1990 Jun; 10(3):160-7. PubMed ID: 2198294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human preference comparison of pentobarbital, diazepam, and placebo.
    Griffiths RR; Bigelow GE; Liebson I
    NIDA Res Monogr; 1981 Feb; 34():220-5. PubMed ID: 6783936
    [No Abstract]   [Full Text] [Related]  

  • 31. Subjective and behavioral effects of diazepam depend on its rate of onset.
    de Wit H; Dudish S; Ambre J
    Psychopharmacology (Berl); 1993; 112(2-3):324-30. PubMed ID: 7871037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychoactivity and abuse potential of sumatriptan.
    Sullivan JT; Preston KL; Testa MP; Busch M; Jasinski DR
    Clin Pharmacol Ther; 1992 Dec; 52(6):635-42. PubMed ID: 1333934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of diazepam and pentobarbital on discrete lever-press avoidance response in mice: baseline-dependent changes.
    Kuribara H; Haraguchi H; Tadokoro S
    Yakubutsu Seishin Kodo; 1985 Dec; 5(4):343-8. PubMed ID: 3832688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacodynamics and pharmacokinetics of ethanol, diazepam and pentobarbital in young and aged rats.
    Guthrie S; Cooper RL; Thurman R; Linnoila M
    Pharmacol Toxicol; 1987 Nov; 61(5):308-12. PubMed ID: 3438226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human sedative self-administration: effects of interingestion interval and dose.
    Griffiths RR; Bigelow GE; Liebson I
    J Pharmacol Exp Ther; 1976 Jun; 197(3):488-94. PubMed ID: 932989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The psychopharmacological effects of premazepam, diazepam and placebo in healthy human subjects.
    Golombok S; Lader M
    Br J Clin Pharmacol; 1984 Aug; 18(2):127-33. PubMed ID: 6148956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial.
    Schoedel KA; Szeto I; Setnik B; Sellers EM; Levy-Cooperman N; Mills C; Etges T; Sommerville K
    Epilepsy Behav; 2018 Nov; 88():162-171. PubMed ID: 30286443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of drug discrimination history on the generalization of pentobarbital to other drugs.
    McMillan DE; Sun WL; Hardwick WC
    J Pharmacol Exp Ther; 1996 Jul; 278(1):50-61. PubMed ID: 8764335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diazepam dose preference in humans.
    Healey ML; Pickens RW
    Pharmacol Biochem Behav; 1983 Mar; 18(3):449-56. PubMed ID: 6835999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug discrimination analysis of partial agonists at the benzodiazepine site. I. Differential effects of U-78875 across training conditions in baboons and rats.
    Ator NA; Griffiths RR
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1434-46. PubMed ID: 10336537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.